Lithium Chloride Alleviates Neurodegeneration Partly by Inhibiting Activity of GSK3β in a SCA3 Drosophila Model

[1]  Li Zhang,et al.  Sodium Valproate Alleviates Neurodegeneration in SCA3/MJD via Suppressing Apoptosis and Rescuing the Hypoacetylation Levels of Histone H3 and H4 , 2013, PloS one.

[2]  Adam Possner,et al.  Cerebellum , 2012, Neurology.

[3]  E. Wanker,et al.  Ku70 Alleviates Neurodegeneration in Drosophila Models of Huntington's Disease , 2011, PloS one.

[4]  M. Lima,et al.  Machado-Joseph Disease: from first descriptions to new perspectives , 2011, Orphanet journal of rare diseases.

[5]  D. Chuang,et al.  Neuroprotective action of lithium in disorders of the central nervous system. , 2011, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[6]  Shinsuke Fujioka,et al.  Autosomal dominant cerebellar ataxia type I: A review of the phenotypic and genotypic characteristics , 2011, Orphanet journal of rare diseases.

[7]  Linda Partridge,et al.  Inhibition of GSK-3 Ameliorates Aβ Pathology in an Adult-Onset Drosophila Model of Alzheimer's Disease , 2010, PLoS genetics.

[8]  D. Rubinsztein,et al.  Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3 , 2009, Brain : a journal of neurology.

[9]  O. Forlenza,et al.  Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease , 2009, European Archives of Psychiatry and Clinical Neuroscience.

[10]  Kostas Vekrellis,et al.  Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells* , 2008, Journal of Biological Chemistry.

[11]  D. Rubinsztein,et al.  Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. , 2008, Nature chemical biology.

[12]  C. Kieling,et al.  Survival estimates for patients with Machado–Joseph disease (SCA3) , 2007, Clinical genetics.

[13]  C. Shaw,et al.  Lithium Therapy Improves Neurological Function and Hippocampal Dendritic Arborization in a Spinocerebellar Ataxia Type 1 Mouse Model , 2007, PLoS Medicine.

[14]  D. Rubinsztein,et al.  The roles of intracellular protein-degradation pathways in neurodegeneration , 2006, Nature.

[15]  D. Rubinsztein,et al.  Inositol and IP3 Levels Regulate Autophagy—Biology and Therapeutic Speculations , 2006, Autophagy.

[16]  D. Rubinsztein,et al.  Rapamycin alleviates toxicity of different aggregate-prone proteins. , 2006, Human molecular genetics.

[17]  P. Taghert,et al.  Lithium- and Valproate-Induced Alterations in Circadian Locomotor Behavior in Drosophila , 2005, Neuropsychopharmacology.

[18]  Claire H. Michel,et al.  Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway. , 2005, Human molecular genetics.

[19]  D. Rubinsztein,et al.  Lithium induces autophagy by inhibiting inositol monophosphatase , 2005, The Journal of cell biology.

[20]  S. Tsuji,et al.  Sharing of polyglutamine localization by the neuronal nucleus and cytoplasm in CAG‐repeat diseases , 2004, Neuropathology and applied neurobiology.

[21]  M. Bianchi,et al.  Functional Studies of Shaggy/Glycogen Synthase Kinase 3 Phosphorylation Sites in Drosophila melanogaster , 2004, Molecular and Cellular Biology.

[22]  Francesco Scaravilli,et al.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.

[23]  H. Pilcher.  Drug research: The ups and downs of lithium , 2003, Nature.

[24]  R. Jope.  Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. , 2003, Trends in pharmacological sciences.

[25]  D. Chakravarti,et al.  Ataxin-3 Is a Histone-binding Protein with Two Independent Transcriptional Corepressor Activities* , 2002, The Journal of Biological Chemistry.

[26]  D. Rubinsztein,et al.  Glycogen Synthase Kinase-3β Inhibitors Prevent Cellular Polyglutamine Toxicity Caused by the Huntington's Disease Mutation* , 2002, The Journal of Biological Chemistry.

[27]  B. Ganetzky,et al.  Temperature-sensitive paralytic mutants are enriched for those causing neurodegeneration in Drosophila. , 2002, Genetics.

[28]  Rainer Duden,et al.  Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. , 2002, Human molecular genetics.

[29]  P. Cohen,et al.  GSK3 takes centre stage more than 20 years after its discovery. , 2001, The Biochemical journal.

[30]  A. Harwood,et al.  Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. , 2001, Biochemical and biophysical research communications.

[31]  G. Moore,et al.  Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. , 2000, The Journal of clinical psychiatry.

[32]  J. Dichgans,et al.  Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3 , 1999, Journal of Neurology.

[33]  P. Salvaterra,et al.  Dynamic visualization of nervous system in live Drosophila. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  N. Bonini.  A genetic model for human polyglutamine-repeat disease in Drosophila melanogaster. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[35]  N. Weigel,et al.  Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. , 1999, Human molecular genetics.

[36]  H. Paulson,et al.  Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. , 1999, Human molecular genetics.

[37]  Nancy M Bonini,et al.  Expanded Polyglutamine Protein Forms Nuclear Inclusions and Causes Neural Degeneration in Drosophila , 1998, Cell.

[38]  H. Topka,et al.  Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. , 1997, Brain : a journal of neurology.

[39]  M. C. Ellis,et al.  Expression of Drosophila glass protein and evidence for negative regulation of its activity in non-neuronal cells by another DNA-binding protein. , 1993, Development.

[40]  H. Paulson.  Machado-Joseph disease/spinocerebellar ataxia type 3. , 2012, Handbook of clinical neurology.

[41]  D. Rubinsztein,et al.  Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies , 2009, Cell Death and Differentiation.